Abstract
Some new papers coming from different Authors are here published, all yet concord in evaluating as excellent the effectiveness of Omalizumab in "difficult" allergic asthmatics. As in a few of the previous articles on Omalizumab published in the most recent issues of this Journal, some of the following case reports are characterized by the application of original evaluation criteria, all concord in defining the efficacy of the drug in treated patients.
| Translated title of the contribution | Different indicators, univocous in the efficacy evaluation of omalizumab |
|---|---|
| Original language | Italian |
| Pages (from-to) | 209-212 |
| Number of pages | 4 |
| Journal | GIMT - Giornale Italiano delle Malattie del Torace |
| Volume | 61 |
| Issue number | 3 |
| Publication status | Published - 2007 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Fingerprint Dive into the research topics of 'Different indicators, univocous in the efficacy evaluation of omalizumab'. Together they form a unique fingerprint.
Cite this
Roma, E., & Banfi, P. (2007). Indicatori diversi, concordi nella valutazione dell'efficacia di omalizumab. GIMT - Giornale Italiano delle Malattie del Torace, 61(3), 209-212.